Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001829126-25-008213·Lazar David E.
Schedule 13D ownership disclosure
NovaBay Pharmaceuticals Inc
Common Stock, $0.01 par value · CUSIP: 66987P409
Event date: 2025-10-16
- Filing-level shares
- 1,502,080.00
- Percent of class
- 19.99%
- David E. LazarReported CIK 0001932843
Shares: 1,502,080.00 · Class: 19.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001829126-25-008213
- Form type
- SCHEDULE 13D/A
- Filer
- Lazar David E.
- CIK
- CIK 1932843
- Filed
- Oct 17, 2025
- Reporting period
- Oct 16, 2025
- Description
- Schedule 13D beneficial ownership